Understanding calcified cerebral embolism in patients
Calcified Cerebral Embolism: a Descriptive Study in a Large Single Center Cohort
This study looks at the features of calcified cerebral embolism in patients to help doctors better understand and manage this condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 79 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nīmes Academic / other |
| Locations | 1 site (Nîmes) |
| Trial ID | NCT06309069 on ClinicalTrials.gov |
What this trial studies
This observational study aims to describe the clinical and radiological characteristics of calcified cerebral embolism (CCE) in a large cohort of patients treated at the CHU de Nîmes. By analyzing data from patients who received intravenous thrombolysis or were diagnosed with CCE via CT scans, the study seeks to identify patterns and differences in radiological features. The findings may enhance the understanding of CCE and its implications for patient management.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have experienced a transient ischemic attack or stroke with evidence of calcified cerebral embolism identified on CT scans.
Not a fit: Patients who do not have calcified cerebral embolism or refuse to allow their data to be used will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the diagnosis and treatment strategies for patients suffering from calcified cerebral embolism.
How similar studies have performed: While there have been small case series on calcified cerebral embolism, this study represents a novel approach by examining a larger cohort to better understand its characteristics.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with CEE treated with intravenous thrombolysis (IVT) between 2015 and 2020 managed at the CHU de Nîmes or Patients with TIA/stroke with ECC identified on CT between 12/2019 and 04/2023 managed at CHU de Nîmes Exclusion Criteria: * Patient's refusal to use his/her data
Where this trial is running
Nîmes
- CHU de Nîmes — Nîmes, France (Recruiting)
Study contacts
- Study coordinator: Teodora PARVU
- Email: teodora.parvu@chu-nimes.fr
- Phone: +33466685008
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.